Skip to content

Medical-device intelligence

GTJ: Antisera, All Groups, N. Meningitidis

FDA product code GTJ: Antisera, All Groups, N. Meningitidis. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GTJ
FDA device name
Antisera, All Groups, N. Meningitidis
Device class
2
Regulation number
866.3390
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

16 clearance records and 5 recall records in the covered releases, across 9 source company names and 1 product codes. Dated history runs from Aug 25, 1977 to Jul 17, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202601
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GTJ · Antisera, All Groups, N. Meningitidis165

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

21 matching records
Device / recordCompany in FDA recordSourceSource date
Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnosticsZ-2927-2026 · GTJRemel Europe Ltd.RecallAug 7, 2026FDA classification date
BD DifcoTM Neisseria Meningitidis Antisera Group Y, 228811, 1mL, in vials, which were labeled in part, 8019456 6250890 N. MEN. GP Y UNLABELED LY…Z-1559-2008 · GTJBD Diagnostic Systems / Lee LaboratoriesRecallAug 8, 2008FDA classification date
BD DifcoTM Neisseria Meningitidis Antisera Group Y 228811, 1mL, in vials, which were labeled in part, 8019456 6250890 N. MEN. GP Y UNLABELED LYOP…Z-1560-2008 · GTJBD Diagnostic Systems / Lee LaboratoriesRecallAug 8, 2008FDA classification date
BD DifcoTM Neisseria Meningitidis Antisera Group Y 241113, 1mL, in vials, which were labeled in part, 8019456 6250890 N. MEN. GP Y UNLABELED LYOP…Z-1561-2008 · GTJBD Diagnostic Systems / Lee LaboratoriesRecallAug 8, 2008FDA classification date
BD DifcoTM Neisseria Meningitidis Antiserum Group Y 241113, 1mL, in vials, which were labeled in part, 8019456 6250890 N. MEN. GP Y UNLABELED LYO…Z-1562-2008 · GTJBD Diagnostic Systems / Lee LaboratoriesRecallAug 8, 2008FDA classification date
DIRECTIGEN MENINGITIS COMBO TESTK952791 · GTJBd Becton Dickinson Vacutainer Systems Preanalytic510(k)May 30, 1996FDA decision date
DIRECTIGEN MENINGITIS COMBO TEST KITK915330 · GTJBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Mar 23, 1992FDA decision date
SLIDEX MENINGITE-KIT 5K910210 · GTJVitek Systems, Inc.510(k)Aug 12, 1991FDA decision date
BACTIGEN(R) N. MENINGITIDISK885004 · GTJArmkel, LLC510(k)Feb 7, 1989FDA decision date
IMMUNOSCAN(TM) DIRECT NEISSERIA MENINGITIDIS KITK870089 · GTJMicroscan Div. Baxter Healthcare Corp.510(k)Mar 17, 1987FDA decision date
WELLCOGEN N. MENINGITIDIS B/E. COLI K1 ZL24K854851 · GTJWellcome Diagnostics510(k)Feb 4, 1986FDA decision date
WELLCOGEN BACTERIAL ANTIGEN KITK854852 · GTJWellcome Diagnostics510(k)Feb 4, 1986FDA decision date
PHADEBACT CSF TESTK844999 · GTJPharmacia, Inc.510(k)Oct 17, 1985FDA decision date
WILLCOGEN MENINGITIDIS KIT ZL25K851691 · GTJWellcome Diagnostics510(k)Jun 10, 1985FDA decision date
MENINGOCOCCUS GROUP B MONOCLONAL ANTIBODY ZM-51K844762 · GTJWellcome Diagnostics510(k)Jun 4, 1985FDA decision date
DIRECTIGEN NEISSENA MENNINGITIDIS GROUP B TESTK844407 · GTJBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Jan 25, 1985FDA decision date
BACTIGEN - N.MENNINIGITIDIS TESTK841907 · GTJArmkel, LLC510(k)Jul 6, 1984FDA decision date
WELLCOGEN N. MENINGITIDIS A,C,Y W135K833063 · GTJWellcome Diagnostics510(k)Jan 10, 1984FDA decision date
BACTIGEN-N. MENINGITIDISK823880 · GTJArmkel, LLC510(k)Mar 9, 1983FDA decision date
PHADEBACT CSF TEST 20K822810 · GTJPharmacia, Inc.510(k)Dec 30, 1982FDA decision date
AGGLUTINATING SERUM W135K771562 · GTJBurroughs Wellcome Co.510(k)Aug 25, 1977FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗